- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01569230
Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Knee Osteoarthritis
April 2, 2012 updated by: Eun Jung Kim
Clinical Trial to Evaluate and Compare the Efficacy and Safety of Individualized and Standardized Acupuncture for Knee Osteoarthritis Patients: Randomized, Single-blind, Controlled Study
The purpose of this study is to verify the efficacy and safety of acupuncture treatments (Individualized, Standardized acupuncture) for patients with knee osteoarthritis (OA).
Study Overview
Status
Unknown
Conditions
Detailed Description
The investigators targeted the patients with knee OA.
After treatment in 4 groups - individualized acupuncture treatment, standardized acupuncture treatment, sham-needle treatment, and waiting groups - the investigators will compare the effects of pain relieving and daily performing improvement.
So the investigators will confirm the efficacy of acupuncture, and further the best treatment method.
In addition, the investigators are going to evaluate the safety of abnormal reaction during the treatment.
Study Type
Interventional
Enrollment (Anticipated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eun Jung Kim, Ph.D.
- Phone Number: +82-31-961-9116
- Email: hanijjung@naver.com
Study Locations
-
-
Gyeonggi-do
-
Goyang, Gyeonggi-do, Korea, Republic of, 410-773
- Recruiting
- Donnguk University Oriental Medical center
-
Contact:
- Eun Jung Kim, Ph.D.
- Phone Number: +82-31-961-9116
- Email: hanijjung@naver.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- At least 20 years of age, but below 80 years of age
- Knee pain from OA in one or both knees in the last 3 months or more
- Presence of knee OA diagnosed by an orthopedist based on American College of Rheumatology classification criteria
- Knee pain from OA in one or both knees rated > 4 cm on a 10 cm Visual Analog Scale (VAS)
- An understanding of the objectives and methods of the clinical trial, and willingness in completing the consent form.
- Those who are reliable and willing to cooperate in this test, and obey the restrictions for the next 3 months
Exclusion Criteria:
- Trauma to or surgery on the knee(s) within 6 months prior to enrollment, causing pain or functional problems
- A history of prolotherapy, injection of hyaluronic acid or cortisone within the last 3 months
- A physical or laboratory finding indicating infection, presence of an autoimmune disease, or inflammatory arthritis
- Serious organic disease, and severe dysfunction due to the medical illness (e.g. Arrhythmia, Angina pectoris, Stroke, Asthma, etc.)
- More severe pain in regions other than the knee joint.
- Pregnant
- When researchers evaluate that it is not appropriate to participate in this clinical test
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Standardized Acupuncture
The patients in this group received standardized acupuncture treatment using the same acupuncture points, applied by a certified Korean Medicine Doctor with more than 6 years of oriental medicine college education and 2 years of clinical experience.
The acupuncture formulas were composed based on literature review of RCTs.
|
The treatment was applied twice a week for 20 minutes for 6 weeks(12sessions) 9 Acupuncture points(SP9,GB34, ST36, ST35, Xiyan(EX-LE5), BL60, GB39, SP6 and KI3)were used for all the patients assigned to this group.
Sterile Stainless Steel(25mm x 40mm) disposable acupuncture needles manufactured by Dong-Bang Acupuncture Co.(Korea) were used.
|
Sham Comparator: Sham acupuncture
Non-penetrating acupuncture device, Park-sham acupuncture, was applied to the patients.
The appearance of the acupuncture is same but the needles do not penetrate the skin.
|
The treatment was applied twice a week for 6 weeks(12sessions).
The sham acupuncture was applied on the 9 same acupuncture points as in the standardized acupuncture group.
Each session was 20 minutes long
Other Names:
|
No Intervention: Waiting
No interventions were applied to the patients in this group.
Only assessments were made at each visit.
|
No interventions were applied to the patients in this group.
Other Names:
|
Experimental: Individualized acupuncture
The patients in this group received individualized acupuncture prescribed by a certified Korean Medicine Doctor with more than 6 years of oriental medicine college education and 2 years of clinical experience.
The acupuncture formulas were composed based on the pattern diagnosis, which is an unique diagnosis system of Oriental Medicine.
|
The treatment was applied twice a week for 20 minutes for 6 weeks(12sessions)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
WOMAC (Western Ontario and McMaster Universities) Scale change
Time Frame: at 2nd(Baseline),8(after 3weeks of treatment),13th(after 6 weeks of treatment) and 14(follow up evaluation after 6 weeks from the last treatment) visit
|
WOMAC scale is checked by the patients.
WOMAC scale is a tool to check of the disability, stiffness and pain by knee pain.
|
at 2nd(Baseline),8(after 3weeks of treatment),13th(after 6 weeks of treatment) and 14(follow up evaluation after 6 weeks from the last treatment) visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
100mm Pain Visual Analogue Scale
Time Frame: at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit
|
The patient is asked to indicate their perceived pain intensity along a 100 mm horizontal line, where '0' represents 'no pain' and '100', 'unbearable pain'.
|
at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit
|
6 Minute walk test
Time Frame: at 2nd(Baseline),8(after 3weeks of treatment),13th(after 6 weeks of treatment) and 14(follow up evaluation after 6 weeks from the last treatment) visit
|
the distance of subject's 6 Minute walking
|
at 2nd(Baseline),8(after 3weeks of treatment),13th(after 6 weeks of treatment) and 14(follow up evaluation after 6 weeks from the last treatment) visit
|
WOMAC pain
Time Frame: at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit
|
The pain part of WOMAC (Westren Ontario and McMaster Universities) Scale
|
at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit
|
Investigator global assessment(IGA)
Time Frame: at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit
|
5 Grading of Investigator(1=Very good, 2=good, 3=fair, 4=poor, 5=very poor)
|
at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit
|
Patient global assessment(PGA)
Time Frame: at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit
|
5 Grading of Investigator(1=Very good, 2=good, 3=fair, 4=poor, 5=very poor)
|
at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit
|
Adverse Events
Time Frame: at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13th(end of treatment) visit
|
Any unpredicted symptoms were checked at each follow up visit and if any, the symptom, time of occurrence, and length of duration were recorded and reported.
|
at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13th(end of treatment) visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kap-Sung Kim, Ph.D., Donnguk University Oriental Medical center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Anticipated)
August 1, 2012
Study Completion (Anticipated)
December 1, 2012
Study Registration Dates
First Submitted
March 26, 2012
First Submitted That Met QC Criteria
March 30, 2012
First Posted (Estimate)
April 3, 2012
Study Record Updates
Last Update Posted (Estimate)
April 4, 2012
Last Update Submitted That Met QC Criteria
April 2, 2012
Last Verified
April 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B080017-KCT0000385
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
-
Max Biocare Pty. Ltd.Completed
Clinical Trials on Individualized Acupuncture
-
New York UniversityNational Institutes of Health (NIH)RecruitingPain | HIV/AIDS | Neuropathic Pain | HIV NeuropathyUnited States
-
Korea Institute of Oriental MedicineCompletedHemodialysis | End Stage Renal DiseaseKorea, Republic of
-
Dongwoo NamGachon University Gil Medical Center; Ministry of Health & Welfare, KoreaUnknownEfficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Low Back PainLow Back PainKorea, Republic of
-
New York UniversityNational Institutes of Health (NIH)UnknownIrritable Bowel SyndromeUnited States
-
NYU Langone HealthNational Institute of Nursing Research (NINR)Completed
-
Korea Institute of Oriental MedicineTerminatedChronic Kidney Disease | End-stage Renal DiseaseKorea, Republic of
-
Lund UniversityRecruiting
-
Charite University, Berlin, GermanyAzienda Sanitaria de Sudtirol, Hospital Meran, Meran, ItalyCompleted
-
Fundacion para la Formacion e Investigacion Sanitarias...RecruitingEpilepsy in ChildrenSpain